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Abstract: Many tissue models have been developed to mimic liver-specific functions for metabolic and
toxin conversion in in vitro assays. Most models represent a 2D environment rather than a complex
3D structure similar to native tissue. To overcome this issue, spheroid cultures have become the gold
standard in tissue engineering. Unfortunately, spheroids are limited in size due to diffusion barriers
in their dense structures, limiting nutrient and oxygen supply. Recent developments in bioprinting
techniques have enabled us to engineer complex 3D structures with perfusion-enabled channel
systems to ensure nutritional supply within larger, densely-populated tissue models. In this study, we
present a proof-of-concept for the feasibility of bioprinting a liver organoid by combining HepaRG and
human stellate cells in a stereolithographic printing approach, and show basic characterization under
static cultivation conditions. Using standard tissue engineering analytics, such as immunohistology
and qPCR, we found higher albumin and cytochrome P450 3A4 (CYP3A4) expression in bioprinted
liver tissues compared to monolayer controls over a two-week cultivation period. In addition, the
expression of tight junctions, liver-specific bile transporter multidrug resistance-associated protein 2
(MRP2), and overall metabolism (glucose, lactate, lactate dehydrogenase (LDH)) were found to be
stable. Furthermore, we provide evidence for the perfusability of the organoids’ intrinsic channel
system. These results motivate new approaches and further development in liver tissue engineering
for advanced organ-on-a-chip applications and pharmaceutical developments.
Keywords: bioprinting; stereolithography; liver equivalent; tissue engineering; bioink; 3D cell-culture;
toxin testing; in vitro testing; drug development
1. Introduction
Engineering tissues for in vitro organ models has always been a challenge. The creation of
complex 3D tissues is motivated by the fact that 3D cell cultures commonly result in biology closely
representing native tissues [1]. Nevertheless, complex tissues require cultivation conditions of elevated
complexity, such as perfusion of the organoid in bioreactors like multi-organ-chips [2]. In order to
empower their full potential, organoids can, not only be cultivated in monocultures resembling specific
cell niches [3], but can also be combined in multi-organ cultures for metabolic and systemic studies [4].
Recent advances in bioprinting technology have enabled us to push the development of complex 3D
tissues for in vitro applications even further, by setting up microfluidic channels within the printed
organ equivalents for perfusion and the possibility of vascularization.
There are many different bioprinting techniques that have introduced additive manufacturing
technology to the field of tissue engineering [5]. Among laser-induced-forward-transfer (LIFT) [6]
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and extrusion-based bioprinting [7], stereolithographic bioprinting combines many advantages and
features the preparation of high-resolution hydrogels [8] with detailed architectures and embedded
vascularization, supplying cell-laden tissues for long-term cultivation [9–12]. Current research pushes
the trends and limitations of bioprinting technology [13], implementing solid-freeform manufacturing,
formerly referred to as a tool for rapid-prototyping [14,15], into cell culture laboratories for tissue
manufacture [16,17]. For the successful printing of tissue models, not only progress in 3D printing
technology, but also the development of suitable bioinks, are necessary. Gelatin-based bioinks
show great promise for embedding cells and creating suitable conditions for the proliferation and
differentiation of many cell types [18–20]. By customizing bioink properties, specific cell–biomatrix
interactions, such as cell migration [21] or directional matrix degradation [22], are controllable.
In view of these developments, many tissue models have already been engineered for in vitro
cell culture applications [23,24]. Ma et al. showed higher liver-specific gene expression levels and
increased metabolic product secretion in a 3D bioprinted liver model consisting of human induced
pluripotent stem cell (hiPSC)-derived hepatic progenitor cells, human umbilical vein endothelial
cells, and adipose-derived stem cells. Furthermore, their model found both phenotypic and
functional enhancements in comparison to 2D monolayer culture [25]. Tsang et al. reported the
fabrication of 3D hepatic tissues by additive photopatterning of modified polyethylenglycol (PEG)
hydrogels, whereas bulk and patterned hydrogels were compared, showing favorable performance in
a continuous flow bioreactor over a 12 day cultivation period [26]. In addition, Lewis et al. reported
architecture-dependent hepatic quality in a 3D printed gelatin scaffold. They found increased albumin
secretion, CYP activity (CYP3A4 and CYP2C9), and bile transport in interconnected scaffolds compared
to different geometries and 2D controls [27]. Other liver tissue models involve polyelectrolyte
multilayer templates to combine primary hepatocytes and fibroblasts in a patterned co-culture. This
approach results in controllable cell–cell and cell–surface interactions, as reported by Kidambi et al. [28].
In a similar approach, Puttaswamy et al. arranged HepG2 cells in a hexagonal liver lobule like structure,
in which cells remained viable despite the application of an electric field for cell manipulation and
positioning [29]. Using an enhanced field-induced dielectrophoresis trap, Ho et al. combined hepatic
and endothelial cells, mimicking the morphology of liver lobule tissue with about 95% cell viability.
Furthermore, an 80% enhancement of CYP1A1 activity was reported compared to non-patterned
pure HepG2 cells [30]. Khetani et al. showed that tissue function depends on hierarchical structures
extending from single cells to functional subunits that coordinate organ functions. In their multiwell
culture system for human liver cells with optimized microscale architectures, phenotypic functions
were maintained for several weeks. Their results emphasized the combination of different technologies
to advance tissue engineering for ‘human-on-a-chip’ applications [31].
Here, we present a bioprinted tissue equivalent, representing the smallest functional unit of the
liver. The printed lobule consists of a hexagonal structure possessing twelve channels running from
the model edges to the central port. Channels are open at both sides, so that fluids can perfuse the
complete construct.
In order to provide basic characterization of the printed liver equivalents, we chose standard
tissue engineering analyses, including quantitative PCR, immunohistochemistry (IHC) staining and
metabolic activity assays. Different protein targets were defined to classify the quality of the printed
tissue compared to HepaRG cells cultivated in monolayer. We focused on albumin, cytochrome P450
3A4 (CYP3A4), cytokeratin 8/18 (Ck8/18), vimentin, multidrug resistance-associated protein 2 (MRP2)
and zonula occludens-1 (ZO-1) expression. Albumin indicates the maturity of hepatocytes, whereby
it is crucial to verify the presence of the protein using IHC [32]. Cytokeratin 8/18 is expressed by
hepatocytes with proliferative capacity, which contribute to the tissues’ regenerative potential [33].
For toxicity screenings, the activity of the Cytochrome P450 enzymes is fundamental. Since CYP3A4 is
one of the most important enzymes of that family, analyses were focused on its expression in order
to provide a proof-of-concept for cytochrome activity in the printed liver equivalent [34,35]. One
of the liver’s main functions is the conversion and transportation of substances. Thereby, the liver
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secretes bile, which is transported inter- and intracellularly by specific transporters. We, therefore, also
investigated the expression of the MRP2, actively controlling bile in- and out-fluxes [36]. Functional
hepatocytes require close cell–cell interactions through tight junctions, which are represented by
peripheral membrane proteins, such as ZO-1 [37]. As the printed liver equivalents, not only contain
HepaRGs, but also stellate cells, we chose vimentin, a protein of mesenchymal origin [38], to visualize
cell distribution within the tissue.
2. Materials and Methods
2.1. Cell Culture
Cell culture components were purchased from Corning and cultures were incubated in HepaRG
medium at 37 ◦C and 5% CO2, unless otherwise stated. HepaRG cells were obtained from Biopredic
International (Rennes, France) and maintained as described by Gripon et al. [39]. Briefly, cells were
cultured in HepaRG medium, consisting of William’s Medium E supplemented with 10% (v/v) fetal
bovine serum (FBS), 100 units mL−1 penicillin, 100 µg mL−1 streptomycin, 5 µg mL−1 human insulin,
2 mM l-glutamine, and 5 × 10−5 M hydrocortisone hemisuccinate (Sigma-Aldrich, St. Louis, MO,
USA). Undifferentiated cells were maintained in 75 cm2 tissue culture flasks (Greiner Bio One, Solingen,
Germany) at a seeding density of 2 × 104 cells cm−2 for two weeks. Induction of differentiation was
initiated by allowing the cells to reach confluence by maintaining the cells in a growth medium for
two weeks. Differentiation medium containing 2% (v/v) dimethyl sulfoxide (DMSO; Carl Roth GmbH,
Karlsruhe, Germany) was added for another two weeks. Human hepatic stellate cells (SteCs) and
their culture supplements were purchased from ScienCell Research Laboratories (Carlsbad, CA, USA).
The cells were seeded at 5 × 103 cells cm−2 in 75 cm2 tissue culture flasks in stellate cell medium for
maintenance, according to the manufacturer’s instructions. Medium was exchanged every three days.
Cells were harvested for further use at 90% confluence.
2.2. Bioink Preparation
For stereolithographic printing, two bioinks based on gelatin and PEG were used. Both bioinks
were synthesized, as previously shown [40,41]. In short, 10 wt % gelatin (porcine skin Type B, Sigma)
was dissolved in phosphate buffered saline (PBS) at 50 ◦C. After, 20-fold molar excess methacrylic
anhydride (Sigma) was added and the reaction continued for 3 h. After reaction, the product
(GelMA) was dialyzed against distilled water. Products were freeze dried and lyophilized for
precise bioink preparation. Degradable PEG-bis-(acryloyloxy acetate) was synthesized in a two-step
reaction. First, PEG-bis-chloroacetate was synthesized by reacting PEG (Sigma) with chloroaceryl
chloride (Sigma). In the second step, acrylic groups were added by reacting the product with
sodium acrylate (Sigma). Products were recovered by precipitation in cold ethylether (Sigma),
dialyzed against distilled water and freeze-dried for long-term storage. The photoinitiator lithium
phenyl-2,4,6-trimethylbenzoy phosphinate was used at 0.1 wt % in all bioinks. For the bioprinting
process, cells were mixed with bioink-solutions containing the photoinitiator to form a bioink cell
suspension ready for photopolymerization.
2.3. Tissue Model and Printing Process
The liver equivalents are designed with hollow channels to allow for perfusion of the organoid.
Within the hexagonal construct, there were twelve channels running from the model edges to a central
port. The channels were open at both sides (Figure 1a). The printed liver model consisted of two
materials. Channels were printed with degradable PEG at 7 wt %. For the cell-containing structures
(Figure 1a, in grey), HepaRGs were harvested, mixed with SteCs 24:1 and resuspended in GelMA,
thereby forming the main bioink at 7% (w/v), possessing a cell density of 10 × 107 cells/mL. A model
mimicking the sinusoidal structure of the liver lobule was designed with a diameter of 4 mm, using
computer-aided design (CAD) software (Rhinoceros 5, McNeel Europe, Barcelona, Spain). The CAD
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file was processed using a Cellbricks Bioprinter and was printed, layer-by-layer. as shown in Figure 1b.
During printing, the bioink was changed automatically according to the material and cells used for the
current structure.
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Figure 1. Cellbricks printing process of liver model. (a) During the printing process, the virtual 3D
model (top view) is translated into a cell-laden multi-material hydrogel; here shown in a 2×microscopic
image; (b) The printing process is visualized schematically. (I) The bioink-cell suspension is filled in the
printers bioink-reservoir. (II) Digital-light-pr cessing (DLP) projection is done l yer-by-layer through
the transparent reservoir bo tom onto the print head. (III) After each layer, the print h ad moves
upwards for the next lay r. (IV) Each layer was photopolymerized onto the previous layer. (V) After
complete printing, the formed tissue model is removed from the print head, ready for cultivation.
During the printing process, each layer of the tissue construct was photopolymerized directly onto
the print head using blue light ill mination for 30 s per layer. Stereolithographic printing technology
enabled us to manufacture six tissue models, in parallel, during one printing proc ss. Each model
contained a total of 106 cells. Aft r rinting, the constructs were detached f om the bioprint r and
placed in a 24- ell plate filled with 1 mL cell culture medium for cultivation. Tissue constructs were
incubated at 37 ◦C and 5% CO2 over 14 days of cultivation time. Two time points, directly after printing
and 14 days after printing, were chosen for analysis. Medium changes were performed every day.
2.3.1. qPCR
Gene expression of albumin, CYP3A4, ZO-1 and MRP2 were analyzed by qPCR, which was
performed directly after printing, on day zero, as a control, and after 14 days of cultivation. RNA
isolation was performed using the NucleoSpin® RNA isolation Kit (Macherey-Nagel, Düren, Germany)
by harvesting the tissue model in RA1 buffer containing 1% β-m rc ptoethanol a cording to the
manufacturer’s protocols. A t tal of 150 ng of RN was reverse tr nscribed into cDNA with the
TaqMan® kit (Applied Biosystem, Foster City, CA, USA), for each sample. Quantitative RT-PCR
experiments were conducted according to the manufacturer’s protocols using the Stratagene system
(Agilent Technologies, Waldbronn, Germany) with a SensiFast SYBR No-ROX One-Step kit (Bioline,
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Luckenwalde, Germany). Used primers and their sequences are presented in Table 1. Cycle threshold
and melting curves were determined using LightCycler software and results were processed using
the 2-∆∆Ct method for relative gene expression analysis [42,43]. Changes in gene expression were
normalized using the TATA-Box binding protein (TBP) as a housekeeping gene. For each time point,
six tissue samples were taken. Monolayer cultures were measured with n = 10. Statistical analyses,
such as the unpaired t-test, were performed in Prism 7 (Graphpad Software, La Jolla, CA, USA).







CYP3A4: cytochrome P450 3A4; ZO-1: zonula occludens-1; MRP2: multidrug resistance-associated protein 2;
TBP: TATA-Box binding protein.
2.4. Immunohistochemistry
For immunohistological analysis, constructs were embedded in Tissue-Tek® (Sakura,
The Netherlands), frozen in liquid nitrogen and cryosectioned at a thickness of 10 µm. Sections
were fixed in acetone at −20 ◦C for 10 min. After washing in PBS and blocking in 10% goat serum for
20 min, immunostaining was performed using primary antibodies (ThermoFisher, Waltham, MA, USA)
targeting albumin, CYP3A4, ZO-1, MRP2, vimentin and cytokeratin 8/18 at 4 ◦C overnight. Secondary
antibodies (goat-anti-mouse and goat-anti-rabbit CF594, Biotium, Fremont, CA, USA) were incubated
for 45 min at room temperature with 1:5000 DAPI for cell nuclei staining. Afterwards, coverslips with
mounting solution were added to seal the staining. Fluorescent microscopy was performed using
a Biorevo BZ-9000 (Keyence, Osaka, Japan). Viability was determined using TUNEL/Ki67 double
staining, using the Apo-Direct Apoptosis Detection Kit (eBioscience, San Diego, CA, USA), according
to the manufacturer’s protocols, in combination with Ki67 antibody (eBioscience, San Diego, CA, USA).
2.5. Metabolic Analysis
Daily medium samples were taken for the determination of glucose-, lactate- and lactate
dehydrogenase (LDH)-content. Absorbance-related measurements were performed in 384-well plates
(Greiner Bio-One, Solingen, Germany) in a microplate-reader (FLUOstar Omega, BMG Labtech,
Ortenberg, Germany). LDH activity in the medium was measured using a Cytotoxicity Detection Kit
PLUS (Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer’s protocols.
The average absorbance per minute (∆A/min), at 450 nm, was determined over three minutes using
medium as a reference. As a positive control, samples were treated with 0.1% Triton X-100 for two
hours and supernatants were analyzed. Daily glucose consumption was measured with the Glucose
Kit Glu 142 (Diaglobal, Berlin, Germany) according to manufacturer’s protocols, using medium as
standard. Lactate concentration was screened in daily medium supernatants using a Lactate Kit Lac
142 (Diaglobal), according to the manufacturer’s protocols. Absorbance was measured at 520 nm using
standards (10 mM/mL) as a reference.
3. Results
3.1. Morphological Analysis after Printing
The printed liver equivalents had a diameter of 4 mm from edge to edge. This size was verified in
all printed constructs. A mean of 4053.6 µm with a standard deviation of 67.2 µm was determined
(based on 30 samples). Multiple tissue constructs printed at the same time displayed high equality
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in morphology and cell distribution. Cells were found within the printed matrix at a high density
and with a homogenous distribution (Figure 2a). The channel–structure was defined by the sacrificial
matrix, as shown in Figure 2a. The channels had a diameter of approx. 200 µm, with a standard
deviation of under 10 µm, as shown in Figure 2a,b. Immediately after printing, some cells were loosely
attached to the model edges. After washing, these cells were removed and only cells that were truly
incorporated within the bioink remained. After three days in culture, the PEG was fully degraded,
as seen in Figure 2, by focusing on the edges (Figure 2b) and the bottom (Figure 2c) of the channel.
Furthermore, we were able to flush the complete channel system, thus demonstrating the organoids’
suitability for cultivation under perfusion (Figure 2d,e and Supplementary Video S1: Perfusion of 3D
bioprinted liver equivalent.).
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Figure 2. Morphology of the printed tissue model. (a) Microscopic picture of liver model directly after
printing. At 10× magnification, the channel-structure is clearly visible. After complete dissolution,
the channel is a hollow structure, as seen by focusing on (b) the edges or (c) the channel bottom.
The channel structure is hollow, as demonstrated by flushing with trypan blue dye (d,e).
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3.2. Viability after Bioprinting
Viability was confirmed by TUNEL/Ki67 staining (Figure 3). Printed liver equivalents showed
high viability throughout the cultivation time of 14 days. Ki67-positive, proliferative cells were
observed at day zero and day 14, whereas TUNEL-positive, apoptotic cells could only be observed
in the positive control treated with Triton X-100. Less proliferative cells were observed at day 14
compared to day zero, right after printing.
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Figure 3. TUNEL/Ki67 staining of printed liver constructs. Proliferative cells (Ki67 positive) are visible
both at day zero and after 14 days of cultivation. Ki67 positive cells appear less at day 14 compared
to day 0. Apoptotic cells (TUNEL positive) were observed in the positive DNase-treated control.
The negative control did not show any unspecific staining.
3.3. Glucose, Lactate and LDH Metabolics
Glucose consumption was observed to be higher at the beginning of cultivation, measuring
around 0.15 mg to 0.3 mg glucose consumption per day (Figure 4a). Complete medium changes with
a maximal glucose concentration of 2 mg per culture were performed every day. Cells treated with
Triton X-100 consumed more than 1.95 g/L glucose per day. LDH levels were observed to be far below
levels of the positive control, indicating viable cells throughout the 14 day of cultivation. LDH levels
started at about 100 mU/mL in the first two days of cultivation, but declined and stabilized around
70 mU/mL in the following days (Figure 4). Tissue constructs treated with Triton X-100 represented the
positive control for apoptotic cells. In these samples, LDH levels rose to 830 mU/mL. Lactate content
was found to be between 3.7 and 6.4 mmol/mL. Similar to observations made for LDH, these levels
were elevated in the first two days of cultivation, dropping down to an average lactate concentration
Genes 2018, 9, 176 8 of 15
of 4.5 mmol/L (Figure 4). Lactate content in pure culture medium without cells was found to be
3 mmol/L (data not shown).Genes 2018, 9, x FOR PEER REVIEW  8 of 15 
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Figure 4. etabolic data of glucose consu ption, lactate dehydrogenase (L ) and lactate
concentration over 14 ays of cultivation. (a) Average glucose consumption ranged from 0.14 to
0.4 g/L. Cells treated with Triton X-100 consumed more than 1.95 g/L. (b) The LDH release started
at about 100 mU/mL, but stabilized at around 70 U/mL three days post-printing. Triton X-100
tr ated cells released 830 mU/mL in average. (c) Lactate c centration was measured between
3.7 and 6.4 mmol/mL. Cells treated with Triton X-10 showed 0.2 mmol/mL lactate concentration in
the culture medium.
3.4. qPCR arker Expression
The following gene expression results for 3D printed liver equivalents and for HepaRG monolayer
cultures are summarized in Figure 5. In printed liver equivalents, albumin expression was found to rise
significantly from day zero to day 14 (Figure 5a). Monolayers showed the opposite effect; a significant
drop in albumin expression from day zero to day 14 was detected. Overall, albumin expression levels
were higher in 3D bioprinted liver equivalents than in HepaRG monolayers. Similar results were
observed in terms of CYP3A4 expression. Gene expression in the bioprinted tissue constructs appeared
to be, on average, 150-fold higher on day 14 compared to day zero. Monolayers showed a significant
drop in CYP3A4 expression from day zero, right after maturation, to day 14, two weeks in culture after
maturation. Overall CYP3A4 expression appeared to be more than seven times higher in 3D bioprinted
tissues compared to monolayer cultures at their highest expression levels (monolayer: Day zero; prints:
Day 14) (Figure 5b). The tight junction protein ZO-1 was expressed in both 3D tissues and monolayer
cultures throughout the experiments with a significant increase of expression in monolayers. Overall
expression levels appeared to be similar, but were slightly higher in monolayers than they were in the
printed liver equivalents at day 14 (Figure 5c). MRP2 expression dropped slightly in bioprinted liver
equivalents and expression remained stable over the two week cultivation. In contrast, the monolayer
demonstrated a significant increase in MRP2 expression levels from day 0 to day 14 (Figure 5d).
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3.5. I unohistoche istry
e ati e co trols for bot t e o ble a si le stai i s o e o s ecific a tibo y
i teractio s (Fig re 6e). I o istoc e istry is s o at ay 14 for vi e ti , cytokerati 8 18,
alb i ( lb), YP3A4 and ZO-1. Vimentin and cytokeratin 8/18 were co-stained visualizing the
cell distribution. Stellate cells visualized by positive staining of vimentin (Figure 6a, i green) were
found to be distributed homogenously throughout the printed tissue. Some accumulation due to cell
roliferatio as observe at t e botto e ge. ytokerati 8 18 as re o i a tly stai e it i
the center of the organoid. nly a fe cytokeratin 8/18-positive cells ere found on the edges, ithin
a ense cell layer surroun ing the hole organoi . oth albu in an P3 4 appeare to be highly
expressed (Figure 6, albumin (b) and CYP3A4 (c)). Their expressions were found to be stronger at day
14 compared to day zero (data not shown). ZO-1 expression was observed in densely-populated areas
throughout the printed tissue (Figure 6f).
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Figure 6. Immunohistochemistry staining of printed liver constructs showing expression patterns of
vimentin (green) co-stained with cytokeratin 8/18 (red) after 14 days of cultivation shown in a complete
section of the print (20× merged) (a). The expression of (b) albumin (Alb), (c) CYP3A4 and (f) ZO-1 is
shown in a single staining after two weeks of cultivation. The location overview (d) shows where each
staining is located within the construct. The negative control (e) verifies the results.
4. Discussion
In this study, we successfully demonstrated the stereolithographic printing principle of a complex
hepatic tissue construct with an intrinsic hollow channel system. The results build a foundation for
future detailed characterization and development of a functional liver model with possible applications
in metabolic and toxicologic assays. The translation of a 3D digital drawing into a highly-structured,
cell-laden hydrogel-based organoid was successfully performed (Figure 2). Right after printing, some
cells were loosely attached to the printed model due to the high cell density within the bioinks. These
cells can easily be washed away, and only the designed structure with the incorporated cells remains.
Multiple tissue constructs, printed at the same time, showed a high equality in morphology and
cell distribution constituting an accurate representation of the intended design for the tissue model,
thus reproducible printing of organoids was demonstrated. Furthermore, apoptotic cells could only
be found in the positive control after two weeks of cultivation (Figure 3). Proliferating cells were
found both at day zero and after two weeks in culture demonstrating a high viability for cultivation
over at least 14 days. More Ki67 positive cells were observed at day 0 compared to day 14, which
indicates a loss of proliferative capacity due to cell differentiation. In this study, we compared HepaRG
cells cultivated in monolayer with the same cells incorporated in the printed lobular constructs. For
both cultivation methods, cells were matured over two weeks in monolayer. Afterwards one half of
the cell culture was printed and cultivated in 3D, the other half remained in the monolayer culture.
Unfortunately, we had to exclude stellate cells from the monolayer controls, as these cultures appeared
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unstable over 14-day cultivation, contracting into an elliptic random construct, whereas monolayers
without stellate cells remained stable over the two week cultivation period. Both monolayer and
printed tissue cultivations were performed over 14 days. Overall gene expression of selected markers
was found to be higher in the printed tissues compared to the monolayer cultures, confirming the
direct effect of the three-dimensional cultivation on the cells’ biology (Figure 5). In the printed liver
equivalents, the tight junction protein ZO-1 was found to be stably expressed over 14 days of cultivation.
At day 14, its standard deviation dropped to a minimum. As cells expressed tight junctions when in
contact with each other, and more organoids showed a higher ZO-1 expression at day 14 compared to
day 0, these results suggest some cell proliferation within the hydrogel. One of the models already
showed maximal expression on day zero, maintaining this level over the entire cultivation time. Since
the cells are pre-differentiated over 14 days in monolayers, detached, suspended in the bioink and
then printed in high cell density, tight junction protein expression might remain high from the first
day on, but this assumption requires further experiments. MRP2 expression was found to increase in
monolayers, whereas there was a slight decrease in expression levels found in printed tissues (Figure 5).
In monolayer cultures, the HepaRGs proliferate until complete confluency, differentiating and forming
bile ducts with transporter expression. In the printed tissues, cells are incorporated in a hydrogel at a
given concentration. Thus, the cells are surrounded by the printed matrix, but not all cells interact
with each other. Cells that expressed MRP2 in the confluent monolayer prior to printing might not
have any cell–cell contact after printing within the gelatin hydrogel. This might explain the decrease
in MRP2 expression in our printed tissues over 14 days of cultivation. An increase in bioink cell
concentration in future organoids might support the expression of MRP2 as more cells stay in contact
with each other, supporting the formation of bile ducts and the main bile acid transporters [36]. There
was a high difference in protein expression at day zero, comparing printed tissue and monolayers,
although the cells were pre-differentiated equally in both experiments. Albumin expression was found
to be two-fold higher and CYP3A4 expression was found to be even 20-fold higher in monolayers,
than in printed tissues, at day zero (Figure 5). This difference can be explained by the procedure
used to take the RNA samples, as different cell handling results in metabolic alterations [44]. For the
monolayers, RNA samples were taken by lysing the attached cells directly from the tissue culture flask
so that no changes in expression were expected. For printed tissues, cells were detached, mixed with
bioink, resulting in a single-cell-suspension, and printed within the hydrogels. Right after the printing
process, the tissue constructs were lysed to extract the RNA. The cells remained in suspension before
the bioprinting process, thus downregulating liver-specific gene expression (albumin, CYP3A4, MRP2).
Only ZO-1 was not affected by this phenomenon in all printed tissues. Nevertheless, this procedure
was chosen to investigate the actual changes in gene expression from day zero to day 14. Monolayer
controls lose albumin and CYP3A4 expression over the two weeks cultivation period. Usually, HepaRG
functionality in monolayers is maintained by adding DMSO after the pre-differentiation. As the printed
tissues are cultivated without DMSO, monolayer cultures were also kept without DMSO, resulting in a
loss of hepatic function. The printed tissues, however, maintained hepatic functionality under these
native conditions.
Protein expression was verified by immunohistology, being in accordance with the results from the
qPCR experiments (Figure 6). Some morphological deformations were observed in cryosections due to
the freezing and cutting procedure of the tissues. As some sections appeared to be squeezed in one
direction (e.g., y-direction, Figure 6a) these deformations were most likely introduced by the cutting
procedure. In Figure 6a,e, a part of the channel structure is visible (black linear area within the staining).
Not all channels are visible at once due to the cutting angle. An accumulation of vimentin positive cells
(stellate cells) was observed at the bottom edge of the tissue section (Figure 6a). As HepaRGs and SteCs
are homogenously mixed in the bioinks, and SteCs were found homogenously distributed throughout
the printed constructs at day zero, this accumulation suggests the proliferation or migration of stellate
cells at this spot. As cells at the edges of the printed tissues might not be fully incorporated in the
printed matrix, they have more space to proliferate and populate the construct surface. Cytokeratin
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8/18-positive cells within the same staining suggest some proliferative hepatocytes, representing an
active tissue with regenerative capabilities.
Metabolic analyses revealed the production of small amounts of lactate (Figure 4c) in accordance
with glucose consumption (Figure 4a). These results suggest oxygen limitation so that glucose
is converted to lactate. The oxygen limitation might be a result of the medium amount used for
cultivation. In this study, the printed tissues were cultivated in a 24-well format with 1 mL of medium.
Manufacturers like Greiner Bio-one suggest using only 0.5 mL of medium in this format. The higher
liquid level limits the amount of oxygen at the bottom of the culture well, where the organoid can
be found [45]. In future experiments, medium levels will need to be adapted and cultivation under
perfusion will help to alleviate this problem. As LDH levels appeared to stay stable after the first
two days (Figure 4, center), the printed tissues stay viable. Metabolic data suggest homeostasis, as no
significant increases or drops in neither glucose consumption nor lactate concentration were visible.
In future experiments, the printed liver organoid will be cultivated in a multi-organ-chip
platform, which facilitates the in- and efflux of oxygen, carbon dioxide, nutrients and metabolites [46].
Co-cultivation with other organ models, such as pancreatic islets, neural tissue or skin, might pose a
promising strategy in testing and optimizing the printed liver equivalents at their current state [4,47,48].
As the channel system allows for perfusion (Figure 2d,e and the supplementary video), adding
endothelial cells to form tight homogenous channel walls is a crucial extension to the development
of this organ model for physiologic perfusion experiments. In native tissue, substances need to pass
endothelial barriers before reaching biological active hepatocytes [49], thus, the addition of endothelial
cells will support hepatic polarization, leading to a higher biological activity and a more detailed
physiology [50,51].
5. Conclusions
In this study, a complex liver organoid was precisely printed using a stereolithographic bioprinting
approach. We were able to print a hollow channel system within the cell-laden hydrogel. The printed
liver tissue equivalents were found to have higher albumin and CYP3A4 expression over a two week
cultivation period, when compared to monolayer controls. Tight junction protein ZO-1 and MRP2
expression remained stable in the printed tissue. However, monolayer controls showed an increase
in the expression of these genes, so there still is potential to adapt cell densities within the printed
organoids. In its current state, we found that the printed liver organoid has great potential for future
lab-on-a-chip and organ-on-a-chip applications, as medium can flow through the channel system
within the tissue model, preparing it for cultivation under perfusion. We successfully established
the stereolithographic printing technology, thus enabling development of the model. Now that we
demonstrated the feasibility of the printing principle, detailed analyses of the major enzymes of the
cytochrome P450 family are crucial to fully characterize the model for applications in metabolic and
toxicology assays. Furthermore, the application of potential toxic substances will give insight into the
enzyme kinetics and overall organoid performance. As our printing technology is constantly being
developed, we aim to incorporate endothelialized channels in the future to support physiologic hepatic
polarization for long-term toxicity screenings. The organoid was established using HepaRG cells, but,
as the presented bioprinting technique it is not limited to cell lines, we suggest the integration of iPSCs
or a primary material for potential personalized medicine applications.
Supplementary Materials: The following supplementary material is available online at http://www.mdpi.com/
2073-4425/9/4/176/s1, Video S1: Perfusion of 3D bioprinted liver equivalent.
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